Skip to main content

Comparative Efficacy of Calcium Antagonists and Beta Blockers in Essential Hypertension

  • Chapter
Essential Hypertension
  • 73 Accesses

Summary

The calcium antagonist drug verapamil was compared in double-blind, double-dummy crossover studies with two beta-adrenoceptor blocking drugs, pindolol and labetalol. All were equally effective as antihypertensive drugs in patients with mild to moderate hypertension. Verapamil caused a fall in blood pressure by reducing total peripheral resistance; since cardiac output rose slightly as judged by echocardiographic studies, verapamil had no adverse effects on airways resistance in patients with obstructive airways disease. The favourable haemodynamic effects and absence of serious side effects suggest that verapamil may represent an important advance in the treatment of mild to moderate hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Prichard BNC, Gillam PMS (1964) Use of propranolol in the treatment of hypertension. Brit Med J 2:275

    Article  Google Scholar 

  2. Morgan TO, Sabto J, Anavekar SN, Louis WJ, Doyle AE (1974) A comparison of beta adrenergic blocking drugs in the treatment of hypertension. Postgrad Med J 50:253

    Article  Google Scholar 

  3. Ligman P, Amery A, dePlane JF, Fagard R, Reybruck T (1976) Hyporeninaemia and hypotensive effect of a cardioselective and a non cardioselective beta blocker. In: Saxona PR, Forsyth RP (eds) Beta adrenoceptor blocking agents. North Holland, Amsterdam, p 229

    Google Scholar 

  4. Fleckenstein A, Tritthart H, Fleckenstein B (1969) A new group of competitive Ca-antagonists (iproveratril, DbOO, prenylamine) with highly potent inhibitory effects on excitation-contraction coupling in mammalian myocardium. Pflugers Arch Ges Physiol 307:R25

    CAS  Google Scholar 

  5. Nay1er WG, Szeto J (1972) Effect of verapamil on contractility, oxygen utilization and calcium exchangeability in mammalian heart muscle. Cardiovasc Res 6:120

    Article  PubMed  CAS  Google Scholar 

  6. Livesley B, Catley PF, Campbell RC, Oram S (1973) Double blind evaluation of verapamil, propranolol and isosorbide nitrate against a placebo in the treatment of angina pectons. Brit Med J i: 375

    Article  Google Scholar 

  7. Lewis GR, Morley KD, Maslowski AH, Bones PJ (1979) Verapamil in the management of hypertensive patients. Aust NZ J Med 9:62

    Article  Google Scholar 

  8. McDonald IG, Feigenbaum H, Chang S (1972) Analysis of left ventricular wall motion by reflected ultrasound: application to assessment of myocardial function. Circulation 46:14

    PubMed  CAS  Google Scholar 

  9. Cooper RH, O’Rourke RA, Karliner JS (1972) Comparison of ultrasound and cineangiography measurement of the mean rate of circumferential fiber shortening. Circulation 96:914

    Google Scholar 

  10. Teicholz LE, Krenlen T, Herman MV, Gorlin R (1976) Problems in echocardiographic volume determination: echocardiographic-angiographic correlations in the presence or absence of synergy. Amer J Card 37:7

    Article  Google Scholar 

  11. Harapat SR, Kates RE (1979) Rapid high pressure liquid chromatographic analysis of verapamil in blood and plasma. J Chromatog 170:385

    Article  CAS  Google Scholar 

  12. Olivari MT, Bartonelli C, Polese A, Fiorantini C, Monuzzi P, Guozzi MD (1979) Treatment of hypertension with nifedipide, a calcium antagonist agent. Circulation 59:1056

    PubMed  CAS  Google Scholar 

  13. Aoki K, Yoshida T, Kato S, Tazumi K, Sato I, Takikawa K, Hotta K (1976) Hypotensive action and increased plasma renin activity by Ca2+ antagonist (nifedipine) in hypertensive patients. Jpn Heart J 17:479

    Article  PubMed  CAS  Google Scholar 

  14. Aoki K, Kondo S, Mochizuki A, Yoshida T, Kato S, Kato K, Takikawa K (1978) Antihyper-tensvie effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J 96:218

    Article  PubMed  CAS  Google Scholar 

  15. Aoki K, Sato K, Kawaguchi Y, Yamamoto M (1982) Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension. Eur J Clin Pharmacol 23:197

    Article  PubMed  CAS  Google Scholar 

  16. Zanchetti A (1981) Perspectives in antihypertensive treatment. In: Zanchetti A, Kribler DM (eds) Calcium antagonism in cardiovascular therapy. Excerpta Medica, Amsterdam, p 292

    Google Scholar 

  17. Burn JH, Gibbons WR (1965) The release of noradrenaline from sympathetic nerve fibres in relation to calcium concentration. J Physiol (Lond) 187:214

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Doyle, A.E. (1986). Comparative Efficacy of Calcium Antagonists and Beta Blockers in Essential Hypertension. In: Aoki, K. (eds) Essential Hypertension. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68048-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68048-2_20

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68050-5

  • Online ISBN: 978-4-431-68048-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics